First let me say I do not read seek’n alpha often, almost all articles seem to have a spin. If I choose to read an article I first look at the author, then review prior titles of their articles. If that passes the smell test, I then skeptically read.
I read this article. The author is Douglas House, his last article was over 2 years ago, he focuses on healthcare and he’s been in the industry.
He provided no opinion, just facts.
The facts speak for themselves, like “35% less risk of urgent/emergent revascularization (stent or bypass surgery)”, if I remember correctly this number is very close to the real World data set Kaiser presented.
We have seen the end of double blind placebo controlled studies as being considered the gold standard...this makes the FDA less relevant.
Best SA article ever Doug.
BB
News 
Market Data 
Discover 
